报价延迟最少15分钟:2026/10/19 01:14 EDT
常规时段
|
|
|
|
|
||||||||||||
|
|
|
|
|
3.49 
|
|
|
| 价值评估 |
|
盈利(现时/预测)
-17.71/-0.65
|
|
企业价值
9.36M
|
| 资产负债 |
|
每股账面净值
-13.08
|
| 现金流量 |
|
现金流量率
--
|
| 损益表 |
|
收益
0
|
|
每股收益
--
|
|
同行比较
|
||||||||||||||||||||||||||||||||||||||||||||||||
|
同行比较之报价最少15分钟延迟 (夜盘时段除外)
|
业务概览
|
|||
| Adial Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on the development of therapeutics for the treatment or prevention of addiction and related disorders. Its investigational new drug candidate, AD04, is being developed as a therapeutic agent for the treatment of alcohol use disorder. The company operates as one operating segment with a focus on drug development for addiction and related disorders. |
